Mölnlycke Is Excellent — But It's Not a One-Stop Shop
Let me get this out of the way upfront: Mölnlycke makes some of the best wound care and surgical products I've ever ordered. But if you're shopping for a holter monitor or a cardiac monitor or trying to figure out what is a mechanical ventilator, well — we need to have an honest conversation about where Mölnlycke fits and where it doesn't.
I'm a procurement manager for a mid-sized hospital network. I've been ordering medical supplies since 2020, processing roughly 200+ orders annually across wound care, surgical, and infection control categories. I report to both operations and finance, so I live at the intersection of clinical need and budget reality.
Here's what I've learned the hard way.
The Safetac® Difference Is Real
Everything I'd read before 2020 said silicone adhesives were all pretty similar. My experience with Mölnlycke's Mepilex and Mepiform changed my mind.
The Safetac® technology isn't just marketing fluff. When you peel a Mepilex dressing off a fragile patient's skin — especially elderly patients with paper-thin skin — you see the difference. Less trauma. Less pain. Fewer dressing changes. That translates to real cost savings, not just clinical preference.
One specific example: we switched from a competitor's silicone foam to Mepilex Border for our pressure injury prevention protocol in Q3 2024. Our wound care nurse tracked a 37% reduction in medical adhesive-related skin injuries (MARSI) over six months. That's not a small number.
But here's the catch: if your facility doesn't see many fragile-skin patients — say you're an orthopedic surgery center treating primarily healthy athletes — the clinical advantage narrows considerably. For those cases, a less expensive silicone dressing might work just fine.
Where Mölnlycke Excels: Three Categories
Based on my experience ordering from them for the past 4 years, here's where they truly shine:
- Wound care dressings — Mepilex, Mepiform, and Melgisorb are consistently reliable. The absorption profile on Melgisorb is noticeably better than alternatives I've used.
- Surgical gloves — Biogel gloves have a reputation for lower allergy rates. We standardized on them in 2023 after a spike in contact dermatitis complaints with another brand.
- Infection prevention — Their Barrier surgical drapes and gowns are well-designed. The fluid control features actually work in practice, not just in marketing materials.
Most buyers focus on per-unit pricing when evaluating these categories. I did too, initially. The question everyone asks is 'what's your best price?' The more important question is 'what's the total cost of care?'
A cheaper dressing that causes more skin breakdown leads to longer hospital stays, more nursing time, and potential penalties from the Centers for Medicare & Medicaid Services (CMS) for hospital-acquired pressure ulcers (HAPU). According to the Agency for Healthcare Research and Quality, HAPUs cost an average of $10,708 per case (as of 2024). Suddenly, a slightly more expensive dressing looks like a bargain.
The Hard Truth: Mölnlycke Isn't for Everyone
Here's where the "honest limitation" comes in. If you're researching holter monitors, cardiac monitors, or asking what is a mechanical ventilator — Mölnlycke is not your vendor for those products.
Their portfolio focuses on wound care and surgical products. Period. They don't make cardiac monitoring equipment or ventilators. That's not a flaw — it's focus.
I've seen procurement colleagues waste weeks trying to get Mölnlycke to quote on patient monitoring systems. Don't be that person. Know what each vendor does well, and match your needs accordingly.
For cardiac monitoring, you're looking at companies like GE Healthcare, Philips, or Nihon Kohden. For mechanical ventilators, consider Dräger, Hamilton Medical, or Getinge. Mölnlycke's strength is in the wound and surgical space — play to their strengths.
But Wait — Doesn't Mölnlycke Offer a Broader Portfolio?
You might be thinking: "But I've seen Mölnlycke products in ORs and patient rooms — don't they make more than just dressings and gloves?"
Fair question. They do have a broader surgical portfolio — drapes, gowns, irrigation solutions, and some infection control products. But their product line stops well short of capital equipment like monitors or ventilators.
I made this mistake myself in early 2022. I assumed a company with Mölnlycke's brand recognition in wound care must also make patient monitors. I spent three weeks researching, reached out to their rep, and felt pretty dumb when she politely explained their focus. Classic outsider blindspot.
What About Price?
Let's address the elephant in the room: Mölnlycke is generally priced at a premium compared to some alternatives. In our 2024 vendor consolidation project, I compared pricing across three wound care suppliers for standard products:
- Mölnlycke Mepilex Border (4x4): ~$3.75/dressing
- Competitor A silicone foam: ~$2.90/dressing
- Competitor B silicone foam: ~$2.40/dressing
On the surface, Mölnlycke looks expensive. But when we factored in reduced dressing change frequency, fewer skin injuries, and lower nursing time, the total cost of care actually favored Mölnlycke for our high-risk patient population.
That said — if you're a small clinic with low patient acuity and a tight budget, the premium may not be justifiable. I'd be dishonest if I told you otherwise.
My Bottom Line Recommendation
Buy Mölnlycke for: wound care dressings (especially for fragile skin), surgical gloves (if latex allergy is a concern), and surgical drapes/gowns (for fluid-intensive procedures).
Don't buy Mölnlycke for: cardiac monitors, holter monitors, mechanical ventilators, or any capital equipment. They don't make those, and trying to fit a square peg in a round hole will waste everyone's time.
Consider alternatives when: your patient population is low-risk, your budget is extremely constrained, or you need a vendor that can bundle wound care with capital equipment.
I recommend Mölnlycke for the 70-80% of facilities that see moderate-to-high acuity wound care patients and value clinical outcomes over upfront savings. For the other 20-30% — you know who you are — a different approach might serve you better. And that's okay.
